Infinity Pharmaceuticals Inc (INFI)

2.00 +0.19  +10.50% NASDAQ Nov 27, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
03/03/2021 Earnings Infinity Pharmaceuticals Inc Fourth Quarter Earnings for 2020 Release
03/03/2021 Misc Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020
11/09/2020 Earnings Infinity Pharmaceuticals Inc Third Quarter Earnings Result for 2020
11/09/2020 16:30 EST Misc Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020
07/30/2020 Earnings Infinity Pharmaceuticals Inc Second Quarter Earnings Result for 2020
07/30/2020 16:30 EDT Misc Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020
06/17/2020 Misc Infinity Pharmaceuticals Inc Annual General Meeting for 2019
05/11/2020 16:30 EDT Misc Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Infinity Pharmaceuticals Inc First Quarter Earnings Result for 2020
03/03/2020 16:30 EST Misc Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.infi.com
  • Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Mar. 03, 2021
  • Last Earnings Release: Nov. 09, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.